UNSPSC 51373464: Guaifenesin/hydrocodone/phenindamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373464 Guaifenesin/hydrocodone/phenindamine is a Commodity code covering pharmaceutical products and related healthcare supplies procured by state and local health and correctional agencies. State and local governments buy controlled substances and related parenteral products under this code—specifically intravenous solutions, parenteral nutrition preparations, and ancillary pharmaceuticals needed to deliver medically necessary care to incarcerated populations and community health programs. The Washington State Department of Corrections exemplifies the primary use case: procurement of parenteral nutrition solutions (TPN and PPN), intravenous solutions, and other controlled substances for eight correctional facilities across the state, with strict delivery windows (24 hours for PN bags, 8 hours for other parenteral products) and compliance requirements including Washington State business licensure, NCIC clearance, and specified insurance coverage. Issuers are typically state correctional or health departments and county health authorities; the Washington DOC and Seminole County, Florida represent the recent activity.

Geographic activity centers on Washington state and Florida based on recent solicitations. The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026 with bids due October 7, 2026, anticipating multiple contractor awards across three regional service areas (West, Central, and East regions) with contract terms running through June 30, 2030 and pricing held firm for the initial two-year period. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building, though the cited due date (July 26, 2023) appears to be a data error. Both solicitations include set-aside encouragement (Washington DOC targets 25% small business, 10% minority-owned, 6% women-owned, and 5% veteran-owned participation) and require compliance with drug-free workplace, E-Verify, and insurance requirements.